Madagascar vs Pakistan: Access to anti-retroviral drugs, male
Madagascar
22.0%
in 2024
Pakistan
14.0%
in 2024
Madagascar rank
139th
Pakistan rank
140th
Access to anti-retroviral drugs, male over time
- Madagascar
- Pakistan
How they compare
Madagascar currently reports 22.0% against 14.0% in Pakistan, a difference of 8.0%.
That makes Madagascar's figure about 1.6 times Pakistan's.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Pakistan ahead.
Madagascar ranks 139th and Pakistan ranks 140th of 141 countries.
Across the 3 decades both report, Madagascar averaged higher in 1 and Pakistan in 2.
Head to head by decade
| Decade | Madagascar | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.4% | 0.9% | 0.5% | Pakistan |
| 2010s | 3.4% | 4.4% | 1.0% | Pakistan |
| 2020s | 15.0% | 10.6% | 4.4% | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Madagascar or Pakistan?
- Madagascar, at 22.0% against 14.0% in Pakistan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Madagascar and Pakistan?
- 8.0%, with Madagascar ahead.
- How many years of comparable data are there for Madagascar and Pakistan?
- 25 years are reported by both, from 2000 to 2024.
- How do Madagascar and Pakistan rank globally for access to anti-retroviral drugs, male?
- Madagascar ranks 139th and Pakistan ranks 140th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.